Cutler Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-219
Closed -$8K 6477
2017
Q2
$8K Sell
219
-63
-22% -$2.06K ﹤0.01% 4394
2017
Q1
$7K Sell
282
-339
-55% -$9.56K ﹤0.01% 4416
2016
Q4
$18K Buy
621
+182
+41% +$4.97K ﹤0.01% 3570
2016
Q3
$11K Sell
439
-134
-23% -$3.03K ﹤0.01% 4118
2016
Q2
$10K Sell
573
-180
-24% -$3.75K ﹤0.01% 4156
2016
Q1
$20K Sell
753
-306
-29% -$8.77K ﹤0.01% 3298
2015
Q4
$31K Buy
+1,059
New +$34K ﹤0.01% 2964

Other funds holding PAHC

Cutler Group's PAHC Position: Q3 2017 in Review

Cutler Group sold out of Phibro Animal Health (PAHC) in Q3 2017, closing a stake of 219 shares — an estimated $8K sold.

Cutler Group first reported a position in PAHC in Q4 2015 and held it in 7 quarters. The position peaked at $31K in Q4 2015. 164 funds tracked by Wall St. Rank hold PAHC as of Q3 2017.

  • Cutler Group reported no remaining Phibro Animal Health position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 219 Phibro Animal Health shares in Q3 2017, an estimated $8K.
  • Cutler Group first reported a position in Phibro Animal Health in Q4 2015 and held it in 7 quarters.
  • Cutler Group's Phibro Animal Health position peaked at $31K in Q4 2015.
  • 164 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.